Literature DB >> 15168589

Second malignant neoplasms following hematopoietic stem cell transplantation.

Debra L Friedman1, Wendy Leisenring, Jeffrey L Schwartz, H Joachim Deeg.   

Abstract

Hematopoietic stem cell transplantation is being successfully used to treat a variety of malignant and nonmalignant disorders. This therapy has resulted in an increasing number of survivors who are at risk for adverse long-term outcomes, including the development of second and subsequent malignant neoplasms. We review the incidence and spectrum of posttransplantation malignancies and discuss risk factors and future directions for research.

Entities:  

Mesh：

Year:  2004        PMID： 15168589     DOI： 10.1532/ijh97.03178

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  22 in total

1.  New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.

Authors:  G Socié; R E Curtis; H J Deeg; K A Sobocinski; A H Filipovich; L B Travis; K M Sullivan; P A Rowlings; D W Kingma; P M Banks; W D Travis; R P Witherspoon; J Sanders; E S Jaffe; M M Horowitz
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

Review 2.  Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation.

Authors:  J Pedersen-Bjergaard; M K Andersen; D H Christiansen
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

3.  Long-term outcome after marrow transplantation for severe aplastic anemia.

Authors:  H J Deeg; W Leisenring; R Storb; J Nims; M E Flowers; R P Witherspoon; J Sanders; K M Sullivan
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

4.  Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation.

Authors:  P A Rowlings; R E Curtis; J R Passweg; H J Deeg; G Socié; L B Travis; D W Kingma; E S Jaffe; K A Sobocinski; M M Horowitz
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

5.  Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  G Socié; P Loiseau; R Tamouza; A Janin; M Busson; E Gluckman; D Charron
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

Review 6.  Secondary leukaemia and myelodysplasia after autografting for lymphoma: is the transplant to blame?

Authors:  D W Milligan
Journal:  Leuk Lymphoma       Date:  2000-10

7.  Solid cancers after bone marrow transplantation.

Authors:  R E Curtis; P A Rowlings; H J Deeg; D A Shriner; G Socíe; L B Travis; M M Horowitz; R P Witherspoon; R N Hoover; K A Sobocinski; J F Fraumeni; J D Boice
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

8.  Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  N Kröger; A R Zander; G Martinelli; P Ferrante; J M Moraleda; G A Da Prada; T Demirer; G Socie; G Rosti
Journal:  Ann Oncol       Date:  2003-04       Impact factor: 32.976

9.  Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

Authors:  Catherine Metayer; Rochelle E Curtis; Julie Vose; Kathleen A Sobocinski; Mary M Horowitz; Smita Bhatia; Joseph W Fay; Cesar O Freytes; Steven C Goldstein; Roger H Herzig; Armand Keating; Carol B Miller; Thomas J Nevill; Andrew L Pecora; J Douglas Rizzo; Stephanie F Williams; Chin-Yang Li; Lois B Travis; Daniel J Weisdorf
Journal:  Blood       Date:  2002-10-10       Impact factor: 22.113

10.  Malignant neoplasms following bone marrow transplantation.

Authors:  S Bhatia; N K Ramsay; M Steinbuch; K E Dusenbery; R S Shapiro; D J Weisdorf; L L Robison; J S Miller; J P Neglia
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113
View more
  9 in total

1.  Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.

Authors:  Debra L Friedman; Alicia Rovo; Wendy Leisenring; Anna Locasciulli; Mary E D Flowers; Andre Tichelli; Jean E Sanders; H Joachim Deeg; Gerard Socie
Journal:  Blood       Date:  2007-10-02       Impact factor: 22.113

2.  Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

Authors:  Catherine J Lee; Soyoung Kim; Heather R Tecca; Stephanie Bo-Subait; Rachel Phelan; Ruta Brazauskas; David Buchbinder; Betty K Hamilton; Minoo Battiwalla; Navneet S Majhail; Hillard M Lazarus; Peter J Shaw; David I Marks; Mark R Litzow; Saurabh Chhabra; Yoshihiro Inamoto; Zachariah DeFilipp; Gerhard C Hildebrandt; Richard F Olsson; Kimberly A Kasow; Jane L Liesveld; Seth J Rotz; Sherif M Badawy; Neel S Bhatt; Jean A Yared; Kristin M Page; Martha L Arellano; Michael Kent; Nosha Farhadfar; Sachiko Seo; Peiman Hematti; César O Freytes; Alicia Rovó; Siddhartha Ganguly; Sunita Nathan; Linda Burns; Bronwen E Shaw; Lori S Muffly
Journal:  Blood Adv       Date:  2020-03-24

3.  Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis.

Authors:  Suk Ho Bhang; Seahyoung Lee; Jung-Youn Shin; Tae-Jin Lee; Hyeon-Ki Jang; Byung-Soo Kim
Journal:  Mol Ther       Date:  2013-01-13       Impact factor: 11.454

4.  Cancer Survivorship Care: Summarizing the 6 Tools for Success.

Authors:  Paulette Mehta; David A Haggstrom; David M Latini; Ellen A Ballard; Jennifer Moye
Journal:  Fed Pract       Date:  2011-09-01

5.  Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).

Authors:  Melissa Gabriel; Bronwen E Shaw; Ruta Brazauskas; Min Chen; David A Margolis; Henrik Sengelov; Ann Dahlberg; Ibrahim A Ahmed; David Delgado; Hillard M Lazarus; Brenda Gibson; Kasiani C Myers; Rammurti T Kamble; Aly Abdel-Mageed; Chi-Kong Li; Mary E D Flowers; Minoo Battiwalla; Bipin N Savani; Navneet Majhail; Peter J Shaw
Journal:  Biol Blood Marrow Transplant       Date:  2017-04-12       Impact factor: 5.742

Review 6.  Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.

Authors:  Nobuko Hijiya; Kirsten K Ness; Raul C Ribeiro; Melissa M Hudson
Journal:  Cancer       Date:  2009-01-01       Impact factor: 6.860

7.  Solid cancers after allogeneic hematopoietic cell transplantation.

Authors:  J Douglas Rizzo; Rochelle E Curtis; Gérard Socié; Kathleen A Sobocinski; Ethel Gilbert; Ola Landgren; Lois B Travis; William D Travis; Mary E D Flowers; Debra L Friedman; Mary M Horowitz; John R Wingard; H Joachim Deeg
Journal:  Blood       Date:  2008-10-29       Impact factor: 22.113

8.  The immunosuppressive effect of the tick protein, Salp15, is long-lasting and persists in a murine model of hematopoietic transplant.

Authors:  Julen Tomás-Cortázar; Itziar Martín-Ruiz; Diego Barriales; Miguel Ángel Pascual-Itoiz; Virginia Gutiérrez de Juan; Alfredo Caro-Maldonado; Nekane Merino; Alberto Marina; Francisco J Blanco; Juana María Flores; James D Sutherland; Rosa Barrio; Adriana Rojas; María Luz Martínez-Chantar; Arkaitz Carracedo; Carolina Simó; Virginia García-Cañas; Leticia Abecia; José Luis Lavín; Ana M Aransay; Héctor Rodríguez; Juan Anguita
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

9.  Survival of patients who develop solid tumors following hematopoietic stem cell transplantation.

Authors:  M J Ehrhardt; R Brazauskas; W He; J D Rizzo; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.